학술논문
Phase I Trial of Anti–Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular Degeneration
Document Type
Article
Author
Source
In Ophthalmology Retina November-December 2017 1(6):474-485
Subject
Language
ISSN
2468-6530